It was subsequently disclosed that IL-15, a cytokine over expressed in celiac disease, could convert the aforementioned IELs into lymphokine-activated killers, which can lyse tumor cell targets in an NKG2D-dependent but TCR-independent manner (Meresse et al., 2004). This evidence concerns the gene KLRK1 and neoplasm.